Facilitated By

San Antonio Medical Foundation

Evaluation of the risk of TB reactivation in BCG vaccinated marmosets treated with IL-17 antagonist, Secukinumab

Texas Biomedical Research Institute

 

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Kaushal, Deepak
Collaborating Institutions
Barshop Institute for Longevity and Aging Studies
Funded by
University of Texas Health Science Center at San Antonio
Research Start Date
Status
Active

19-003 We propose a study to investigate the risk of TB reactivation in BCG vaccinated marmosets that are treated with Secukinumab. Role: PI

Collaborative Project
Basic Research
Disease Modeling
Infectious Disease